Showing results (1-10 of 547) with videos related to
Sort By:
Pageof 55
Blood|June 10, 2021
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimalElihu Estey, Robert P Hasserjian, Hartmut DöhnerBest Practice & Research. Clinical Haematology|December 3, 2014
Management of persistent AML at day 14Elihu EsteyHematology. American Society of Hematology. Education Program|January 18, 2011
High cytogenetic or molecular genetic risk acute myeloid leukemiaElihu EsteyMediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Therapeutic Options for Patients who are not Eligible for Intensive ChemotherapyElihu EsteyBest Practice & Research. Clinical Haematology|November 29, 2016
Why are there so few randomized trials for patients with primary refractory acute myeloid leukemia?Elihu EsteyHaematologica|October 2, 2009
Do commonly used clinical trial designs reflect clinical reality?Elihu EsteyBest Practice & Research. Clinical Haematology|December 1, 2011
What is the optimal induction strategy for older patients?Elihu EsteyPageof 55